Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort
Sofia Chiatamone Ranieri(Sapienza University of Rome), Roberto Latagliata(Ospedale di Belcolle), Emilia Baldacci(Sapienza University of Rome), Alessio Di Prima(Sapienza University of Rome), Sara Pepe(Sapienza University of Rome), Gioia Colafigli(Policlinico Umberto I), Serena Rosati(Sapienza University of Rome), Emilia Scalzulli(Policlinico Umberto I), Maria Cristina Scamuffa(Policlinico Umberto I), Maria Antonietta Arleo(Sapienza University of Rome), Ida Carmosino(Policlinico Umberto I), Cristina Santoro(Sapienza University of Rome), Marco Vignetti(Fondazione Gimema Onlus), Elena Mariggiò(Policlinico Umberto I), Luisa Bizzoni(Sapienza University of Rome), Marco Mancini(Radboud University Nijmegen), Stefania Trasarti(Sapienza University of Rome), Maria Lucia De Luca(Sapienza University of Rome), Massimo Breccia(Policlinico Umberto I), Daniela De Benedittis(Sapienza University of Rome), Antonietta Ferretti(Policlinico Umberto I), Sara Mohamed(Royal College of Surgeons in Ireland - Bahrain), Matteo Molica(Sapienza University of Rome)
Cited by 2
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
|Cytokine|2015|505
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464